Abstract
The two taxanes (paclitaxel and docetaxel) are widely employed in standard antineoplastic practice. Although these agents are now well established, some toxic side effects have been reported. Toxicity of these agents includes bone marrow suppression (principally neutropenia), hypersensitivity reactions, cutaneus reactions, edema and neurotoxicity. The most prominent neurotoxicity is a sensory neuropathy. Controlling neuropathy is crucial for maintaining the quality of life of patients because it is usually persistent and hard to manage. The precise mechanism for taxane-induced neuropathy is still unknown. The taxanes are known to promote aggregation of intracellular microtubules. Abnormal aggregation of micro-tubules in the neuronal cells may cause this neuropathy. In addition, the taxanes have been suggested to have intrinsic toxicity and directly injure the cells. A better understanding of the mechanism for this neuropathy may improve the quality of life of patients who undergo taxane antineoplastic therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- MTs:
-
Microtubules
- NGF:
-
Nerve growth factor
References
Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC: Neurotoxicity of Taxol.J Natl Cancer Inst Monogr 15:107–115, 1993.
Markman M: Managing taxane toxicities.Support Care Cancer 11:144–147, 2003.
Kuroi K, Bando H, Saji S, Toi M: Weekly schedule of docetaxel in breast cancer: evaluation of response and toxicity.Breast Cancer 10:10–14, 2003.
Hilkens PH, ven den Bent MJ: Chemotherapy-induced peripheral neuropathy.J Peripher Nerv Syst 2:350–361, 1997.
Quasthoff S, Hartung HP: Chemotherapy-induced peripheral neuropathy.J Neurol 249:9–17, 2002.
Gelmon K: The taxoids: paclitaxel and docetaxel.Lancet: 344 1267–1272, 1994.
Rowinsky EK, Donehower RC: Paclitaxel (taxol).N Engl J Med 332:1004–1014, 1995.
Schiff PB, Fant J, Horwitz SB: Promotion of micro-tubule assembly in vitro by taxol.Nature 277:665–667, 1979.
Parness J, Horwitz SB: Taxol binds to polymerized tubulin in vitro.J Cell Biol 91:479–487, 1981.
Letourneau PC, Ressler AH: Inhibition of neurite initiation and growth by taxol.J Cell Biol 98:1355–1362, 1984.
Letourneau PC, Shattuck TA, Ressler AH: Branching of sensory and sympathetic neuntes in vitro is inhibited by treatment with taxol.J Neurosci 6:1912–1917, 1986.
Lipton RB, Apfel SC, Dutcher JP, Rosenberg R, Kaplan J, Berger A, Einzig AI, Wiernik P, Schaumburg HH: Taxol produces a predominantly sensory neuropathy.Neurology 39:368–373, 1989.
Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ: Paclitaxel-induced neuropathy.Ann Oncol 6:489–494, 1995.
Sahenk Z, Barohn R, New P, Mendell JR: Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings.Arch Neurol 51:726–729, 1994.
Apfel SC: Docetaxel neuropathy.Neurology 46:2–3, 1996.
Hilkens PH, Verweij J, Stoter G, Vecht CJ, van Putten WL, van den Bent MJ: Peripheral neurotoxicity induced by docetaxel.Neurology 46:104–108, 1996.
New PZ, Jackson CE, Rinaldi D, Burns H, Barohn RJ: Peripheral neuropathy secondary to docetaxel (Taxotere).Neurology 46:108–111, 1996.
Hilkens PH, Verweij J, Vecht CJ, Stoter G, van den Bent MJ: Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere).Ann Oncol 8:187–190, 1997.
Chaudhry V, Chaudhry M, Crawford TO, Simmons-O’Brien E, Griffin JW: Toxic neuropathy in patients with pre-existing neuropathy.Neurology 60:337–340, 2003.
Roytta M, Raine CS: Taxol-induced neuropathy: further ultrastructural studies of nerve fiber changes in situ.J Neurocytol 14:157–175, 1985.
Cavaletti G, Tredici G, Braga M, Tazzari S: Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol.Exp Neurol 133:64–72, 1995.
Hamers FP, Pette C, Neijt JP, Gispen WH: The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats.Eur J Pharmacol 233:177–178, 1993.
Vahdat L, Papadopoulos K, Lange D, Leuin S, Kaufman E, Donovan D, Frederick D, Bagiella E, Tiersten A, Nichols G, Garrett T, Savage D, Antman K, Hesdorffer CS, Balmaceda C: Reduction of paclitaxel-induced peripheral neuropathy with glutamine.Clin Cancer Res 7:1192–1197, 2001.
Apfel SC, Lipton RB, Arezzo JC, Kessler JA: Nerve growth factor prevents toxic neuropathy in mice.Ann Neurol 29:87–90, 1991.
Hayakawa K, Sobue G, Itoh T, Mitsuma T: Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion expiants in vitro.Life Sci 55:519–525, 1994.
De Santis S, Pace A, Bove L, Cognetti F, Properzi F, Fiore M, Triaca V, Savarese A, Simone MD, Jandolo B, Manzione L, Aloe L: Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.Clin Cancer Res 6:90–95, 2000.
Gwag BJ, Sessler FM, Robine V, Springer JE: Endogenous glutamate levels regulate nerve growth factor mRNA expression in the rat dentate gyrus.Mol Cells 7:425–430, 1997.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hagiwara, H., Sunada, Y. Mechanism of taxane neurotoxicity. Breast Cancer 11, 82–85 (2004). https://doi.org/10.1007/BF02968008
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02968008